Sleep apnea & the oxygen story

This is the hidden epidemic of sleep: close to a billion people have obstructive sleep apnea and most don't know it. But the deeper point the headline numbers miss is that you don't need full-blown apnea for your oxygen to dip and your sleep to shatter.

Obstructive sleep apnea

The airway collapses

In OSA the airway repeatedly collapses during sleep, each event ending in a gasp or arousal. Severity is graded by the apnea-hypopnea index (AHI): 5–15 mild, 15–30 moderate, over 30 severe. It affects an estimated ~1 billion adults — the majority undiagnosed — and untreated it independently drives high blood pressure (especially resistant), atrial fibrillation, stroke, insulin resistance, and higher mortality. Evidence ●●●●●

UARS & 'light apnea'

What a normal AHI misses

You can have significant airway trouble that a standard apnea count calls 'normal.' Upper airway resistance syndrome (UARS) and effort-related arousals fragment sleep without meeting the apnea threshold — classically in younger, thinner people, often women, the opposite of the stereotype. If you have every symptom of disordered breathing but a 'normal' home test, this is the leading reason — and it takes a full lab study to catch. Evidence ●●●○○

The oxygen-drop mechanism

Desaturation → arousal → blood pressure

Here's the part most people miss: you don't need a full apnea to be harmed. A transient dip in blood oxygen (or just airflow limitation) triggers a micro-arousal that fragments sleep, fires the fight-or-flight system, spikes blood pressure, and blunts HRV — potentially hundreds of times a night. The oxygen desaturation index (ODI) counts these dips, and even sub-apnea nocturnal desaturation raises cardiovascular risk. Not every desaturation is 'sleep apnea' — but every one taxes your sleep and your heart. Evidence ●●●●○

The treatments work

How it's fixed

CPAP is the gold standard and highly effective. Alternatives include mandibular advancement (oral) appliances, positional therapy, myofunctional (airway-muscle) exercises, and ENT surgery. For the obesity-driven type, significant weight loss helps — and GLP-1 drugs (tirzepatide) are now FDA-approved for moderate-severe apnea after roughly halving events in trials. Hypoglossal-nerve stimulation (Inspire) is an option for the CPAP-intolerant. Evidence ●●●●●

A 'normal' home test doesn't clear you

Home apnea tests are built to catch moderate-to-severe disease and can miss mild apnea and UARS entirely. If you still wake unrefreshed after a 'normal' result, ask specifically about upper airway resistance and a full in-lab study — and track your overnight oxygen in the meantime.